Adaptive Biotechnologies
Adaptive Biotechnologies develops sequencing assays that characterize the adaptive immune system for research and biopharmaceutical industry.
Business Model:
Revenue: $168M
Employees: 501-1,000
Industries / Tags:
Detailed Adaptive Biotechnologies Information
Geographic Data
Address: 1551 Eastlake Avenue E
City: Seattle
State: WA
Zip: 98102
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$0
Raised Total:$407M
Social
Metrics
1,647,532Website Global Rank
14,524Website Monthly Traffic
Twitter Followers
Description
Adaptive Biotechnologies develops sequencing assays that characterize the adaptive immune system for research and biopharmaceutical industry.
Contact Phone:
+18554668667
Contact Email:
Adaptive Biotechnologies went public on 6/26/2019 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/26/2019
IPO Valuation:
$2B
Ticker Symbol:
ADPT
IPO Price:
$20/share
Amount Raised:
$300M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 1/2015 | Sequenta |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
